Genetically modified rodents and rodent cells, and uses thereof

EP4757593A1Pending Publication Date: 2026-06-17CAMBRIDGE ENTERPRISE LTD

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
CAMBRIDGE ENTERPRISE LTD
Filing Date
2024-08-09
Publication Date
2026-06-17

Smart Images

  • Figure EP2024072588_13022025_PF_FP_ABST
    Figure EP2024072588_13022025_PF_FP_ABST
Patent Text Reader

Abstract

Transgenic rodents and rodent cells that express components of the human immune system, and their uses in generating human T cell receptors (TCRs). A genetically modified rodent comprising a TCR alpha gene locus comprising unrearranged human TCR alpha variable gene segments and a human TCR alpha constant region, and a TCR beta gene locus comprising unrearranged human TCR beta variable gene segments and a human TCR beta constant region. Use of hTCR transgenic rodents to generate antigen-specific CD8+ T cell responses for the discovery of fully human TCR sequences with therapeutic potential.
Need to check novelty before this filing date? Find Prior Art